168 related articles for article (PubMed ID: 38065873)
1. Micropapillary or solid component predicts worse prognosis in pathological IA stage lung adenocarcinoma: A meta-analysis.
Wang Y; Hu J; Sun Y; Lu Y
Medicine (Baltimore); 2023 Dec; 102(49):e36503. PubMed ID: 38065873
[TBL] [Abstract][Full Text] [Related]
2. Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
Wang Y; Song W; Wang X; Che G
Pathol Res Pract; 2023 Feb; 242():154314. PubMed ID: 36706587
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
4. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis.
Wang W; Hu Z; Zhao J; Huang Y; Rao S; Yang J; Xiao S; Cao R; Ye L
J Cardiothorac Surg; 2020 Jun; 15(1):154. PubMed ID: 32600473
[TBL] [Abstract][Full Text] [Related]
5. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
6. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
8. Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.
Cha MJ; Lee HY; Lee KS; Jeong JY; Han J; Shim YM; Hwang HS
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):921-928.e2. PubMed ID: 24199757
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
[TBL] [Abstract][Full Text] [Related]
10. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study].
Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347
[No Abstract] [Full Text] [Related]
11. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
12. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma.
Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
Oncology; 2024; 102(4):366-373. PubMed ID: 37899040
[TBL] [Abstract][Full Text] [Related]
15. Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.
Gao S; Stein S; Petre EN; Shady W; Durack JC; Ridge C; Adusumilli P; Rekhtman N; Solomon SB; Ziv E
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):253-259. PubMed ID: 28770314
[TBL] [Abstract][Full Text] [Related]
16. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C
J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components.
Li Y; Zhao J; Zhao Y; Li R; Dong X; Yao X; Xia Z; Xu Y; Li Y
Cancer Med; 2024 Feb; 13(3):e7030. PubMed ID: 38400663
[TBL] [Abstract][Full Text] [Related]
18. Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis.
Bertoglio P; Aprile V; Ventura L; Cattoni M; Nachira D; Lococo F; Perez MR; Guerrera F; Minervini F; Querzoli G; Bocchialini G; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Bogina GS; Solli P; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Gnetti L; Terzi AC
Lung; 2022 Oct; 200(5):649-660. PubMed ID: 35988096
[TBL] [Abstract][Full Text] [Related]
19. Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence.
Chen C; Chen ZJ; Li WJ; Pan XF; Wen YY; Deng T; Le HB; Zhang YK; Zhang BJ
Ann Diagn Pathol; 2022 Aug; 59():151945. PubMed ID: 35397312
[TBL] [Abstract][Full Text] [Related]
20. The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.
Zombori T; Nyári T; Tiszlavicz L; Pálföldi R; Csada E; Géczi T; Ottlakán A; Pécsy B; Cserni G; Furák J
Virchows Arch; 2018 Jun; 472(6):949-958. PubMed ID: 29611055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
